565 related articles for article (PubMed ID: 2105329)
1. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.
Hall JE; Whitcomb RW; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329
[TBL] [Abstract][Full Text] [Related]
2. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist.
Hall JE; Brodie TD; Badger TM; Rivier J; Vale W; Conn PM; Schoenfeld D; Crowley WF
J Clin Endocrinol Metab; 1988 Sep; 67(3):524-31. PubMed ID: 3137243
[TBL] [Abstract][Full Text] [Related]
3. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
[TBL] [Abstract][Full Text] [Related]
4. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH.
Dubourdieu S; Charbonnel B; D'Acremont MF; Carreau S; Spitz IM; Bouchard P
J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622
[TBL] [Abstract][Full Text] [Related]
5. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).
Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB
J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507
[TBL] [Abstract][Full Text] [Related]
6. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
[TBL] [Abstract][Full Text] [Related]
7. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
[TBL] [Abstract][Full Text] [Related]
8. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women.
Couzinet B; Lahlou N; Thomas G; Thalabard JC; Bouchard P; Roger M; Schaison G
Clin Endocrinol (Oxf); 1991 Jun; 34(6):477-83. PubMed ID: 1716186
[TBL] [Abstract][Full Text] [Related]
9. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
[TBL] [Abstract][Full Text] [Related]
10. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum.
McLachlan RI; Cohen NL; Vale WW; Rivier JE; Burger HG; Bremner WJ; Soules MR
J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men.
Lindner J; Rivier JE; Vale WW; Pavlou SN
J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
Apter D; Bützow TL; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist.
Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ
J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone-dependent regulation of gonadotropin subunit messenger ribonucleic acid levels in the rat.
Wierman ME; Rivier JE; Wang C
Endocrinology; 1989 Jan; 124(1):272-8. PubMed ID: 2491805
[TBL] [Abstract][Full Text] [Related]
15. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Couzinet B; Young J; Brailly S; Chanson P; Schaison G
J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.
Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS
J Androl; 1994; 15(1):22-8. PubMed ID: 8188535
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis).
Weinbauer GF; Nieschlag E
Andrologia; 1993; 25(3):141-7. PubMed ID: 8517553
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone-induced stimulation and desensitization of free alpha-subunit secretion mirrors luteinizing hormone and follicle-stimulating hormone in perifused rat pituitary cells.
Weiss J; Duca KA; Crowley WF
Endocrinology; 1990 Nov; 127(5):2364-71. PubMed ID: 2121462
[TBL] [Abstract][Full Text] [Related]
19. Failure of gonadotropin-releasing hormone (GnRH) pulses to increase luteinizing hormone beta messenger ribonucleic acid in GnRH-deficient female rats.
Kerrigan JR; Dalkin AC; Haisenleder DJ; Yasin M; Marshall JC
Endocrinology; 1993 Nov; 133(5):2071-9. PubMed ID: 8404655
[TBL] [Abstract][Full Text] [Related]
20. Addition of a gonadotropin releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilization (IVF) cycles: physiologic observations and preliminary experience.
Paulson RJ; Sauer MV; Lobo RA
J Assist Reprod Genet; 1994 Jan; 11(1):28-32. PubMed ID: 7949832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]